Skip to main content
PharmaCielo Ltd. logo

PharmaCielo Ltd. — Investor Relations & Filings

Ticker · PCLO ISIN · CA71716K1012 LEI · 5493002XOFWMT83TYQ57 TSXV Manufacturing
Open in API
Filings indexed 389 across all filing types
Latest filing 2022-05-30 Regulatory Filings
Country CA Canada
Listing TSXV PCLO

About PharmaCielo Ltd.

https://www.pharmacielo.com/

PharmaCielo Ltd. is a global supplier specializing in the cultivation, processing, and distribution of medicinal-grade cannabis extracts and dried flower. The company focuses on ethical and sustainable production, aiming to be a leading partner in the global medicinal cannabis market. Utilizing ideal equatorial conditions, PharmaCielo operates large-scale, high-efficiency production facilities, including 12 hectares of open-air greenhouses, enabling four full crops annually for reliable supply. Its product portfolio includes standardized extracts, such as high-purity CBD Isolate, and both psychoactive and non-psychoactive derivatives. Production adheres to pharmaceutical-quality standards, supported by proprietary genetics maintained in a tissue culture lab and advanced processing facilities ensuring consistency and safety.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – English.pdf
Regulatory Filings
2022-05-30 English
News release - English.pdf
Regulatory Filings
2022-05-30 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing PharmaCielo's initial shipment of CBD full spectrum oil to a Spanish pharmaceutical company, marking the company's entry into the Spanish market. It contains management commentary and forward-looking statements but does not include any financial statements, detailed financial results, or regulatory filings. The content is focused on a business update and market expansion rather than financial reporting or regulatory compliance. It is not an earnings release, annual or interim report, audit report, or any other formal financial filing. Therefore, it fits best as a Regulatory Filing (RNS), which is a general category for miscellaneous announcements that do not fit other specific categories.
2022-05-24 English
News release - English.pdf
Regulatory Filings
2022-05-11 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a partnership agreement between PharmaCielo and Soteria Holdings Limited to license, import, and wholesale medical cannabis products in Poland. It includes management commentary, company background, and forward-looking statements. There are no financial statements, regulatory certifications, voting results, or detailed financial data. The content focuses on a business partnership and strategic market expansion rather than financial results or regulatory filings. The document length is 5485 characters, which is relatively short and typical for a press release. This type of announcement fits best under the category of Capital/Financing Update (CAP), as it relates to a strategic business agreement and market expansion involving licensing and distribution, which can be considered a financing or capital-related update for the company.
2022-05-06 English
News release - English.pdf
Earnings Release Classification · 90% confidence The document is a press release announcing PharmaCielo's financial results for the fourth quarter and fiscal year ended December 31, 2021. It includes summary financial figures such as revenue, EBITDA, net income, and cash equivalents, but does not contain full financial statements or detailed analysis. It also discusses a private placement financing update. The document is not the full annual report (10-K) or interim report (IR), nor is it a management discussion and analysis (MDA) or earnings release (ER) in the strict sense, as it provides more than just key highlights but less than a full report. Given the presence of financial results and financing update, and the nature of the document as an announcement rather than a full report, the best fit is Earnings Release (ER). The document length (7673 characters) supports it being a detailed earnings release rather than a brief announcement or a full report. FY 2021
2022-04-29 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.